Amy Flynt
Impact in
-
- Chemokine receptors and signaling
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
-
- Immunotherapy and Immune Responses
Papers in
-
- Cancer Mechanisms and Therapy 4
- Oncology 5
- Lung Cancer Research Studies 4
- Chemokine receptors and signaling 4
- Peptidase Inhibition and Analysis 1
- Co-authors
- John R. Stille (6 shared papers)John Polzer (5 shared papers)Stephanie Roberson (6 shared papers)Oday Hamid (5 shared papers)Eyas Raddad (5 shared papers)Ravi Salgia (3 shared papers)Michael McCleod (3 shared papers)David R. Spigel (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Orthopaedic Trauma (1 paper)Investigational New Drugs (1 paper)Lung Cancer (1 paper)Targeted Oncology (1 paper)
- Partner nations
- United StatesBelgiumAustralia
In The Last Decade
Amy Flynt
14 papers receiving 309 citations
Peers
Comparison fields: 5 of 58
- Oncology 130
- Immunology 75
- Epidemiology 103
- Microbiology 16
- Endocrinology, Diabetes and Metabolism 38
Countries citing papers authored by Amy Flynt
This map shows the geographic impact of Amy Flynt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Flynt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Flynt more than expected).
Fields of papers citing papers by Amy Flynt
This network shows the impact of papers produced by Amy Flynt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Flynt. The network helps show where Amy Flynt may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Flynt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 55 | |
| 2 | 2016 | 54 | |
| 3 | 2012 | 51 | |
| 4 | 2022 | 44 | |
| 5 | 2017 | 36 | |
| 6 | 2017 | 35 | |
| 7 | 2020 | 12 | |
| 8 | 2012 | 7 | |
| 9 | 2015 | 7 | |
| 10 | 2018 | 4 | |
| 11 | 2015 | 3 | |
| 12 | 2017 | 2 | |
| 13 | 2015 | 1 | |
| 14 | 2022 | 1 |
About Amy Flynt
Amy Flynt is a scholar working on Pathology and Forensic Medicine, Oncology, Epidemiology, Infectious Diseases and Surgery, having authored 14 papers that have together received 312 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Cancer Mechanisms and Therapy (4 papers), Chemokine receptors and signaling (4 papers), Influenza Virus Research Studies (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Respiratory viral infections research (2 papers), Chronic Kidney Disease and Diabetes (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (130 citations), Immunology (75 citations), Epidemiology (103 citations), Microbiology (16 citations) and Endocrinology, Diabetes and Metabolism (38 citations). Amy Flynt has collaborated with scholars based in United States, Belgium and Australia. Frequent co-authors include John R. Stille, John Polzer, Stephanie Roberson, Oday Hamid, Eyas Raddad, Ravi Salgia, Michael McCleod, David R. Spigel, Joanne Sloan‐Lancaster and James A. Reeves. Their work appears in journals such as Journal of Clinical Oncology, Journal of Orthopaedic Trauma, Investigational New Drugs, Lung Cancer and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.